Revision history of "ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Fct)" (Q3673255)

22 March 2024

• curprev 15:0815:08, 22 March 2024‎ DG Regio talk contribs‎ 135,562 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.7211058936981887

7 December 2023

• curprev 14:5514:55, 7 December 2023‎ DG Regio talk contribs‎ 135,274 bytes +2,967‎ ‎Changed an Item

11 August 2022

• curprev 12:4212:42, 11 August 2022‎ DG Regio talk contribs‎ 132,307 bytes +96,251‎ ‎Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

13 January 2022

• curprev 23:4523:45, 13 January 2022‎ DG Regio talk contribs‎ 36,056 bytes +5,096‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations
• curprev 06:5306:53, 13 January 2022‎ DG Regio talk contribs‎ 30,960 bytes +4,890‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

6 December 2021

• curprev 12:1412:14, 6 December 2021‎ DG Regio talk contribs‎ 26,070 bytes +4,968‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

1 December 2021

• curprev 06:5606:56, 1 December 2021‎ DG Regio talk contribs‎ 21,102 bytes +4,901‎ ‎Created claim: summary (P836): Immuntherapie, die auf die Interaktion tPA/NMDA-Rezeptor zur Behandlung von Erkrankungen des Zentralnervensystems ausgerichtet istDieses Projekt ist Teil des RIS3-Bereichs "Biomedizinische Wissenschaften und Technologien" und ist in der Kontinuität eines Labels "FRM-Team (Stiftung für medizinische Forschung; 2014-17). Dieses Projekt ist der Entwicklung einer Immuntherapie für mehrere Erkrankungen des Zentralnervensystems (ZNS) gewidmet. Es stüt...

27 November 2021

• curprev 11:4911:49, 27 November 2021‎ DG Regio talk contribs‎ 16,201 bytes −4,939‎ ‎Removed claim: summary (P836): Immunothérapie ciblant l‚interaction tPA/récepteur NMDA pour le traitement des pathologies du système nerveux centralCe projet s‘inscrit dans le domaine RIS3 „sciences et technologies biomédicales et est en continuité d’un label“Equipe FRM (Fondation pour la Recherche Médicale; 2014-17). CE projet est dédié à l‚élaboration d‘une immunothérapie pour plusieurs maladies du système nerveux central (SNC). Il repose sur plus de dix ans d‚expertise...

26 November 2021

• curprev 22:2622:26, 26 November 2021‎ DG Regio talk contribs‎ 21,140 bytes +4,939‎ ‎Created claim: summary (P836): Immunothérapie ciblant l‚interaction tPA/récepteur NMDA pour le traitement des pathologies du système nerveux centralCe projet s‘inscrit dans le domaine RIS3 „sciences et technologies biomédicales et est en continuité d’un label“Equipe FRM (Fondation pour la Recherche Médicale; 2014-17). CE projet est dédié à l‚élaboration d‘une immunothérapie pour plusieurs maladies du système nerveux central (SNC). Il repose sur plus de dix ans d‚expertise de...
• curprev 14:0814:08, 26 November 2021‎ DG Regio talk contribs‎ 16,201 bytes +252‎ ‎Changed label, description and/or aliases in de: translated_label

24 November 2021

• curprev 15:3615:36, 24 November 2021‎ DG Regio talk contribs‎ 15,949 bytes +431‎ ‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string

18 November 2021

• curprev 10:3110:31, 18 November 2021‎ DG Regio talk contribs‎ 15,518 bytes +242‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 10:3110:31, 18 November 2021‎ DG Regio talk contribs‎ 15,276 bytes +4,385‎ ‎Created claim: summary (P836): Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of diseases of the central nervous system This project is part of the RIS3 field “biomedical sciences and technologies and is continuing a label”FRM Team (Foundation for Medical Research; 2014-17). This project is dedicated to the development of immunotherapy for several diseases of the central nervous system (CNS). It relies on more than ten years of expertise in the mecha...

17 November 2021

• curprev 11:0811:08, 17 November 2021‎ DG Regio talk contribs‎ 10,891 bytes +6‎ ‎Changed label, description and/or aliases in en: Setting new description
• curprev 11:0811:08, 17 November 2021‎ DG Regio talk contribs‎ 10,885 bytes +10,885‎ ‎Created a new Item: importing one item from France